Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease

Saba Sayari, Hassan Neishaboori, Maryam Jameshorani

Clin Mol Hepatol. 2018;24(3):331-338. Published online June 12, 2018

DOI: https://doi.org/10.3350/cmh.2018.0006

View: 8543 Download: 183 Web of Science: 31 Crossref: 35

Editorial

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?

Yong Kyun Cho

Clin Mol Hepatol. 2018;24(3):299-301. Published online September 7, 2018

DOI: https://doi.org/10.3350/cmh.2018.1006

View: 5835 Download: 106

Original Article

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

View: 7950 Download: 66 Web of Science: 2 Crossref: 2

4

An adult case of glycogen storage disease type IIIa

Kyeong Ok Kim, M.D., Heon Ju Lee, M.D., Jae Won Choi, M.D., Jong Ryul Eun, M.D., Joon Hyuk Choi, M.D.

Clin Mol Hepatol. 2008;14(2):219-225. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.219

View: 4758 Download: 57 Crossref: 2

3

Prostaglandin A₂ Induces Caspase-independent Apoptosis in Hepatocellular Carcinoma Cells

Ho Shik Kim , Jae Chun Shim , Ju Youn Choi , Hyang Shuk Rhim , In Kyung Kim

Clin Mol Hepatol. 2005;11(1):72-79. Published online January 1, 2000

View: 2226 Download: 12

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4733	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search